ArticleBlood neoplasia2026

Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade.

Reid W Merryman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.